Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension

被引:17
作者
Landray, MJ
Edmunds, E
Li-Saw-Hee, FL
Hughes, BA
Beevers, DG
Kendall, MJ
Lip, GYH [2 ]
机构
[1] Univ Birmingham, Div Med Sci, Queen Elizabeth Hosp, Birmingham B18 7QH, W Midlands, England
[2] Univ Birmingham, City Hosp, Dept Med, Div Med Sci, Birmingham B18 7QH, W Midlands, England
关键词
D O I
10.1093/qjmed/95.3.165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Low-density lipoprotein (LDL) consists of a heterogeneous group of particles of varying size and electrophoretic mobility. A predominance of small, more mobile particles is a risk factor for cardiovascular disease. Aim: To investigate the hypothesis that untreated patients with essential hypertension in the absence of vascular disease may exhibit abnormalities of LDL subfractions. Setting: Specialist hypertension clinic. Design: Cross-sectional study. Methods: Following disc polyacrylamide gel electrophoresis, the mean (LDL locus) and heterogeneity (LDL spread) of mobility was recorded in 41 patients (mean age 52.6 years, 24 men) presenting with untreated essential hypertension (in the absence of vascular disease or diabetes mellitus) and in 45 healthy controls (age 56.9 years, 22 men) recruited from primary-care lists. Results: Although there were no significant differences in total, low- or high-density lipoprotein cholesterol concentrations, LDL locus was significantly greater in the hypertensive group: mean (95%Cl) 36.7 (35.7-37.6) vs. 34.8 (34.1-35.5), p=0.002. LDL locus was significantly elevated even in hypertensives with triglyceride concentrations below the median (< 1.25 mmol/l). LDL spread was also greater in the hypertensive group, but not significantly: 5.6 (5.2-6.0) vs. 3.5 (5.3-5.8), P=0.10. Discussion: Hypertensive patients have a preponderance of smaller LDL subfractions. This dyslipidaemia is not readily detected by conventional lipid assays.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 30 条
  • [1] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [2] BLOOMFIELD H, 1999, NEW ENGL J MED, V341, P410
  • [3] FENOFIBRATE AND LDL METABOLIC HETEROGENEITY IN HYPERCHOLESTEROLEMIA
    CASLAKE, MJ
    PACKARD, CJ
    GAW, A
    MURRAY, E
    GRIFFIN, BA
    VALLANCE, BD
    SHEPHERD, J
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (05): : 702 - 711
  • [4] ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS
    DEGRAAF, J
    HAKLEMMERS, HLM
    HECTORS, MPC
    DEMACKER, PNM
    HENDRIKS, JCM
    STALENHOEF, AFH
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02): : 298 - 306
  • [5] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
    Downs, JR
    Clearfield, M
    Weis, S
    Whitney, E
    Shapiro, DR
    Beere, PA
    Langendorfer, A
    Stein, EA
    Kruyer, W
    Gotto, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
  • [6] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [7] Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
    Gardner, CD
    Fortmann, SP
    Krauss, RM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11): : 875 - 881
  • [8] EFFECTS OF CIPROFIBRATE ON LDL METABOLISM IN MAN
    GAW, A
    PACKARD, CJ
    CASLAKE, MJ
    GRIFFIN, BA
    LINDSAY, GM
    THOMSON, J
    VALLANCE, BD
    WOSORNU, D
    SHEPHERD, J
    [J]. ATHEROSCLEROSIS, 1994, 108 (02) : 137 - 148
  • [9] APOLIPOPROTEIN, LOW-DENSITY LIPOPROTEIN SUBFRACTION, AND INSULIN ASSOCIATIONS WITH FAMILIAL COMBINED HYPERLIPIDEMIA - STUDY OF UTAH PATIENTS WITH FAMILIAL DYSLIPIDEMIC HYPERTENSION
    HUNT, SC
    WU, LL
    HOPKINS, PN
    STULTS, BM
    KUIDA, H
    RAMIREZ, ME
    LALOUEL, JM
    WILLIAMS, RR
    [J]. ARTERIOSCLEROSIS, 1989, 9 (03): : 335 - 344
  • [10] HURTCAMEJO E, 1990, J LIPID RES, V31, P1387